x

Search for a clinical trial

* (*) mandatory field

A Phase 2b Efficacy and Safety Study of PTC124 in Subjects with Nonsense Mutation Mediated Duchenne and Becker Muscular Dystrophy - SE

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Ptc therapeutics, inc.
  • Website
    • Phase : II
  • Principal investigator of clinical trial

  • Pr Thomas SEJERSEN
  • Pediatric Neurology
  • Karolinska University Hospital
  • Astrid Lindgren Children's Hospital - Karolinska
  • 17176 STOCKHOLM
  • SWEDEN
  • More information
  • Phone  : 46 8 51770000
  • Fax  : -
Last update: July 2012

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.